Synonym/Acronym
plasma renin activity (PRA), angiotensinogenase.
Rationale
To assist in evaluating for a possible cause of hypertension.
Patient Preparation
There are no fluid restrictions unless by medical direction. The patient should be on a normal sodium diet (12 g sodium per day) for 2 to 4 wk before the test. Inform the patient or family member that the position required for specimen collection (supine for infants or upright for children and adults) must be maintained for 15 to 30 min before specimen collection. By medical direction, the patient should avoid diuretics, antihypertensive drugs, herbals, cyclic progestogens, and estrogens for 2 to 4 wk before the test. Protocols may vary among facilities.
Normal Findings
Method: Liquid chromatography tandem mass spectrometry.
Age and Upright Position | Conventional Units | SI Units (Conventional Units × 1) |
---|---|---|
Newborn12 mo | 235 ng/mL/hr | 235 mcg/L/hr |
Normal sodium diet | ||
Children (415 yr) | Equal to or less than 6 ng/mL/hr | Equal to or less than 6 mcg/L/hr |
Greater than 15 yradultolder adult | 0.24.3 ng/mL/hr | 0.24.3 mcg/L/hr |
Restricted sodium diet | ||
1839 yr | 2.924 ng/mL/hr | 2.924 mcg/L/hr |
Greater than 40 yr | 2.910.8 ng/mL/hr | 2.910.8 mcg/L/hr |
Aldosterone-Renin Ratio | Less than 25 |
Values vary according to the laboratory performing the test, as well as the patients age, gender, dietary pattern, state of hydration, posture, and physical activity.
(Study type: Blood collected in a lavender-top [EDTA] or pink-top [K2-EDTA] tube; related body system: . Specify patient position [upright or supine] and exact source of specimen [peripheral versus arterial]. Venipuncture should be performed after the patient has been in the upright [sitting or standing] position for 1530 min. If a supine specimen is requested on an inpatient, the specimen should be collected early in the morning before the patient rises. The specimen should be immediately transported in an ice slurry to the laboratory.)
Renin is an enzymatic peptide hormone secreted by the granular cells of the juxtaglomerular apparatus in the kidney in response to sodium depletion and hypovolemia. Renin activates the renin-angiotensin system through the conversion of angiotensinogen to angiotensin I. Angiotensin I is converted to the biologically active angiotensin II by angiotensin-converting enzyme primarily within the capillaries of the lungs. Angiotensin II is a powerful vasoconstrictor that ultimately maintains the appropriate perfusion pressure in the kidneys. Angiotensin II stimulates aldosterone production in the adrenal cortex, secretion of antidiuretic hormone from the pituitary, and stimulates the thirst reflex from the hypothalmus. The net effect is regulation of blood pressure by regulating arterial vasoconstriction and the movement of extracellular fluids such as plasma, lymphatic fluid, and interstitial fluid. Excessive amounts of angiotensin II cause renal hypertension. The random collection of specimens without prior dietary preparations does not provide clinically significant information. Values should also be evaluated along with simultaneously collected aldosterone levels (see studies titled Aldosterone and Angiotensin-Converting Enzyme). Measurement of the aldosterone/renin ratio (ARR) from an adrenal venous sampling technique is the gold standard to distinguish between adrenal cortex adenoma (a benign unilateral hyperplasia that can be surgically corrected) and bilateral hyperplasia (treated medically with aldosterone antagonists). For additional information regarding the ARR, refer to the study titled Aldosterone.
Increased In
Decreased In
Before the Study: Planning and Implementation
Teaching the Patient What to Expect
Potential Nursing Actions
After the Study: Implementation & Evaluation Potential Nursing Actions
Treatment Considerations
Nutritional Considerations
Clinical Judgement
Follow-Up Evaluation and Desired Outcomes